Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXTENZA in concomitant MIGS and cataract surgery
NCT04200651Phase 4Terminated
- Sponsor
- New York Eye Surgery Center
- Start
- Jan 2020
- Primary completion
- Jul 2023
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in post-operative ocular inflammation, post-operative ocular pain, sponsored by New York Eye Surgery Center. Started Jan 2020; status: terminated.
02
Drugs
ozurdex
03
Conditions
post-operative ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on NCT04200651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04200651.